Table 1 Summary of the articles reviewed for individuals with overweight and obesity (n = 11) with an overview of the participant characteristics, exercise protocol, exercise supervision, outcome variables, equipment used, and the main findings related to vascular functions.
Author | Participants characteristics | Exercise protocol | Exercise supervision | Outcome variable | Equipment used | Main findings | |
|---|---|---|---|---|---|---|---|
HIIT | MICT | ||||||
Farahati et al. [36] | 33 women who are inactive and overweight | 85%–95% HRmax, 4 × 4 min, 3 S WK−1, 12 WK | 60%–70% HRmax Treadmill Walking, 47 min, 3 S WK−1, 12 WK | Supervised | Carotid IMT (mm) | Doppler ultrasound, M-Turbo, Sonosite America | MICT ↔ HIIT ↔ control ↔ |
HIIT (n = 10); 42.8 ± 2.69 yrs; 29.2 ± 2.28 kg/m² | Overall ABI | Doppler ultrasound, M-Turbo, Sonosite America | MICT ↔ HIIT ↔ control ↔ | ||||
MICT (n = 11); 43.9 ± 3.8 yrs; 30.79 ± 2.79 kg/m² | Right ABI | Doppler ultrasound, M-Turbo, Sonosite America | MICT↔ HIIT↑15%* control ↔ | ||||
Control (n = 9); 44.22 ± 3.63 yrs; 31.63 ± 3.97 kg/m² | Left ABI | Doppler ultrasound, M-Turbo, Sonosite America | MICT↔ HIIT↔ Control↔ | ||||
Tucker et al. [35] | 28 men who are overweight and obese | 90%–95% HRmax Cycling, 8–11 × 1 min, 4 S W−1, 4 WK | 50% VO2 max cycling, 30–40 min, 4 S W−1, 4 WK | Supervised | FMD | Terason t3000CV Ultrasound, Terason, Burlington, MA | HIIT↔ MICT↔ CON↔ |
HIIT (n = 10); 30 ± 7 yrs; 96.0 ± 7.7 kg; 30.2 ± 3 kg/m² | Baseline diameter | Terason t3000CV Ultrasound, Terason, Burlington, MA | HIIT↔ MICT↔ CON↔ | ||||
MICT (n = 9); 29 ± 7 yrs; 94.5 ± 18.6 kg; 29.7 ± 4.5 kg/m² | Peak diameter | Terason t3000CV Ultrasound, Terason, Burlington, MA | HIIT↔ MICT↔ CON↔ | ||||
Control (n = 9); 28 ± 9 yrs; 93.1 ± 11.8 kg; 29.6 ± 3.9 kg/m² | Peak shear stress | Terason t3000CV Ultrasound, Terason, Burlington, MA | HIIT↔ MICT↔ CON↔ | ||||
Mean blood velocity | Terason t3000CV Ultrasound, Terason, Burlington, MA | HIIT↔ MICT↔ CON↔ | |||||
Baekkerud et al. [34] | 30 overweight and obese | Supervised | Venous compliance | 4HIIT↔ 1 HIIT↔ MICT↔ | |||
4HIIT (n = 12); 39 ± 10 yr; 91.7 ± 17.4 kg; BMI, 31.4 ± 5.3 kg/m² | 85%–95% HRmax Treadmill walking, 4 × 4 min, 3 S WK−1, 6 WK | 70% HRmax Steady state running/walking, 45 min, 3 S WK−1, 6 WK | Peak venous outflow | 14-MHz Doppler probe, Vivid 7 System; GE Vingmed Ultrasound, Horten, Norway | 4HIIT↔ 1 HIIT↔ MICT↓22.7% | ||
1HIIT (n = 9); 45 ± 8 yr; 91.1 ± 10.1 kg; 30.8 ± kg/m² | 90% HRmax, 10 × 1 min, 3 S WK−1, 6 WK | Arterial inflow | 14-MHz Doppler probe, Vivid 7 System; GE Vingmed Ultrasound, Horten, Norway | 4HIIT↔ 1 HIIT↔ MICT↓ 15.7% | |||
MICT (n = 9) 41 ± 10 yr; 89.5 ± 12.4 kg; 29 ± 2.7 kg/m² | FMD | 14-MHz Doppler probe, Vivid 7 System; GE Vingmed Ultrasound, Horten, Norway | 4HIIT↔ 1 HIIT↔ MICT↔ | ||||
Shepherd et al. [29] | 90 individuals who are healthy, inactive and overweight | >90% HRmax Sprints, 15–60 s, 18–25 min, 5 S WK−1, 10 WK | ~70% HRmax Cycling, 30 min (WK 1)–45 min (WK 10), 5 S WK−1, 10 WK | 3 supervised 2 unsupervised | AIx@75bpm | – | HIIT↔ MICT↔ |
HIT (n = 46); 42 ± 11 yrs; 78.8 ± 18.3 kgs; 27.7 ± 5.0 kg/m² | |||||||
MICT (n = 44); 43 ± 11 yrs; 77.5 ± 15.8 kgs; 27.7 ± 4.6 kg/m² | |||||||
Shenouda et al. [23] | 27 men who are sedentary, overweight | All out cycling sprints against 5.0% body weight, 3× 20 s, 30 S, 12 WK | 70% HRmax Cycling, 45 min, 30 S, 12 WK | Supervised | Brachial artery diameter (BAD) | Artery Measurement System (AMS) II, version 1.141; Gothenburg, Sweden | Resting BAD HIIT↑0.5% MICT↑8% Control ↑3% |
HIIT (n = 9); 27 ± 7 yrs; 84 ± 23 kg; 27 ± 5 kg/m² | FMD | Doppler ultrasounds (Vivid Q; GE Medical Systems, Horten, Norway) | HIIT↔ MICT↔ CNT ↔ | ||||
MICT (n = 10); 28 ± 9 yrs; 84 ± 20 kg; 26 ± 6 kg/m² | Popliteal artery diameter | Artery Measurement System (AMS) II, version 1.141; Gothenburg, Sweden | HIIT↔ MICT↔ CNT↔ | ||||
Control (n = 6); 26 ± 8 yrs; 78 ± 25 kg; 25 ± 7 kg/m² | FMD | Doppler ultrasounds (Vivid Q; GE Medical Systems, Horten, Norway) | HIIT↔ MICT↔ CNT↔ | ||||
Carotid distensibility | Doppler ultrasound (Vivid Q, GE Medical Systems) & applanation tonometry (model SPT-301, Millar Instruments, Houston, TX) | HIIT↔ MICT↔ CNT↔ | |||||
PWV | Applanation tonometry (Mikro-Tip Catheter Transducer, model SPT-301; Millar Instruments) | HIIT↔ MICT↔ CNT↔ | |||||
Chin et al. [22] | 56 men who are overweight; 18–30 yrs; 26.4 ± 2.9 kg/m² | ||||||
HIIT 3 (n = 14) | 90% HRR 30-m Shuttle run, 12 × 1 min, 3 S WK−1, 8 WK | 60% HRR running, 30 min, 3 S WK−1, 8 WK | Supervised | LnRHI | EndoPAT 2000 (ITAMAR Medical, Caesarea, Israel) | HIIT 3↔ HIIT2↔ HIIT 1↔ MICT↔ | |
HIIT 2 (n = 10) | 90% HRR 30-m Shuttle run, 12 × 1 min, 2 S WK−1, 8 WK | AIx@75 | EndoPAT 2000 (ITAMAR Medical, Caesarea, Israel) | HIIT 3↔ HIIT2↔ HIIT 1↔ MICT↔ | |||
HIIT 1 (n = 9) | 90% HRR 30-m Shuttle run, 12 × 1 min, 1 S WK−1, 8 WK | ||||||
MICT (n = 9) | |||||||
Control (n = 14) | |||||||
Cheema et al. [30] | 12 adults with BMI >25 kg/m² | >75% HRmax, RPE of 15-17/20 Boxing, 4 S × 50 min WK−1, 12 WK | Brisk Walking, 4 S × 50 min WK−1, 12 WK | HIIT: Supervised MICT: unsupervised | AIx | SphygmoCor System (AtCor Medical Pty, Sydney, Australia) | HIIT ↓126.7%* MICT ↔ |
HIIT (n = 6); 43 yrs; 95.7 kg; 32.0 kg/m² | Pulse pressure | Fidelity tonometer (Millar Instruments, Houston, Texas) | HIIT ↔ MICT ↔ | ||||
MICT (n = 6); 36 yrs; 85.6 kg; 30.8 kg/m² | |||||||
Cocks et al. [31] | 16 men who are sedentary and obese | 200% Wmax Cycling, 1–3 S 4 reps, ↑1 rep every 3 S, 3 S WK−1, 4 WK | ̴65% VO2 peak Cycling, 1–7 S 40 min, 8–14 S 50 min, 15–20 S 60 min, 5 S WK−1, 4 WK | Supervised | AIx | SphygmoCor, AtCor Medical, Sydney, Australia | HIIT↓* MICT↓* |
HIIT (n = 8); 24 ± 2 yrs; 110 ± 5 kg; 35.8 ± 0.8 kg/m² | cPWV | SphygmoCor, AtCor Medical, Sydney, Australia | HIIT↓* MICT↓* | ||||
MICT (n = 8); 26 ± 2 yrs; 113 ± 6 kg; 33.7 ± 1.5 kg/m² | pPWV | SphygmoCor, AtCor Medical, Sydney, Australia | HIIT↔ MICT↔ | ||||
Sawyer et al. [19] | 18 adults who are obese M(18–45 yrs); F(18–55 yrs) | 90%–95% HRmax Cycling, 10 × 1-min, 24 S:3 S WK−1, 8 WK | 70–75% HRmax Cycling, 30 min, 24 S:3 S WK−1, 8 WK | Supervised | Preocclusion baseline diameter | Terason t3000 high resolution (Terason Ultrasound, Burlington, MA) | HIIT ↔ MICT ↑4.9%* |
HIIT (n =9); 37.4 ± 6.2 kg/m² | Postocclusion peak diameter | Terason t3000 high resolution (Terason Ultrasound, Burlington, MA) | HIIT ↑5%* MICT ↔ | ||||
MICT (n = 9); 34.5 ± 3.2 kg/m² | |||||||
Flow-mediated dilation | Terason t3000 high resolution (Terason Ultrasound, Burlington, MA) | HIIT ↑*3.8% MICT ↔ | |||||
Shear rate area under the curve | Terason t3000 high resolution (Terason Ultrasound, Burlington, MA) | HIIT ↓28%* MICT ↔ | |||||
Average velocity, cm/s | Terason t3000 high resolution (Terason Ultrasound, Burlington, MA) | HIIT ↓23%* MICT ↔ | |||||
Average diameter, mm | Terason t3000 high resolution (Terason Ultrasound, Burlington, MA) | HIIT ↑4.8%* MICT ↔ | |||||
Schjerve et al. [32] | 40 adults who are obese | 85%–95% HRmax, 4 × 4 min, 3 S WK−1, 12 WK | 60–70% HRmax Walking, 40 min, 3 S WK−1, 12 WK | 2 supervised 1 unsupervised | Flow-mediated dilation | High-resolution vascular ultrasound 14MHz echo Doppler probe; Vivid 7 system; GE Vingmed Ultrasound | HIIT greater ↑* MICT↑* ST↑* |
HIIT (n = 14); 46.9 ± 2.2 yrs; 114.0 ± 5.7 kg; 36.6 ± 1.2 kg/m² | BA baseline diameter | HIIT↔ MICT↔ ST↔ | |||||
MICT (n = 13); 44.4 ± 2.1 yrs; 104.1 ± 4.5 kg; 36.7 ± 1.4 kg/m² | BA Shear rate | HIIT↔ MICT↔ ST↔ | |||||
ST (n = 13); 46.2 ± 2.9 yrs; 98.8 ± 4.5 kg; 34.5 ± 1.4 kg/m² | 90% 1RM leg press, 4 × 5 reps, Abdominal and Back Ex 3 × 30 reps, 3 S WK−1, 12 WK | Peak NTG diameter | HIIT↔ MICT↔ ST↔ | ||||
Shi et al. [33] | 52 adults who are obese 18–22 years, ≥30 kg/m² | 80%–95% HRmax Ex, WK 1–2: 40 s, 25 min Ex, WK 3–5: 60 s 35 min Ex, WK 6–8: 60 s 45 min EX, 3–4 S WK−1, 8 WK | 60%–70% HRmax Ex, 45 min, 3–4 S WK−1, 8 WK | Supervised | Blood volume | Doppler ultrasound (Prosound Alpha 7, Aloka, Japan) | HIIT ↑11.5%* MICT ↑18.1%* CON ↔ |
HIIT (n = 21) | Flow rate | Doppler ultrasound (Prosound Alpha 7, Aloka, Japan) | HIIT↔ MICT↔ CON↔ | ||||
MICT (n = 22) | Wall shear stress | Doppler ultrasound (Prosound Alpha 7, Aloka, Japan) | HIIT ↑21.6%* MICT ↑16.9%* CON ↔ | ||||
Control (n = 9) | OSI | Doppler ultrasound (Prosound Alpha 7, Aloka, Japan) | HIIT ↓* MICT ↔ CON ↔ | ||||
Arterial diameter | Doppler ultrasound (Prosound Alpha 7, Aloka, Japan) | HIIT ↓6%* MICT ↔ CON ↔ | |||||
Arterial stiffness | Doppler ultrasound (Prosound Alpha 7, Aloka, Japan) | HIIT ↓18.8%* MICT ↔ CON ↔ | |||||
Circumferential strain | Doppler ultrasound (Prosound Alpha 7, Aloka, Japan) | HIIT ↑18.1%* MICT ↔ CON ↔ | |||||
Pulsatility index | Doppler ultrasound (Prosound Alpha 7, Aloka, Japan) | HIIT ↓7%* MICT ↔ CON ↔ | |||||